Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SCN4A | P35499 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10548438 | 0.83 | MAOB (0.47) | LTA4HPTGS1LMNATSHRALDH1A1 | |
| SCHEMBL10552651 | 0.83 | RXRA (0.46) | MAOA | |
| SCHEMBL3227309 | 0.83 | SLC6A4 (0.41) | SLC6A4SCN4ASLC7A5EPHX1LTA4H | |
| SCHEMBL11504410 | 0.82 | KDM4E (0.38) | SLC6A4SCN4ASLC7A5MAOAPTGS1 | |
| SCHEMBL10550130 | 0.80 | ACHE (0.41) | MAOALMNATSHRALDH1A1 | |
| SCHEMBL3229708 | 0.79 | LTA4H (0.44) | SLC6A4SLC7A5LTA4HMAOAALDH1A1 | |
| SCHEMBL11504723 | 0.79 | KDM4E (0.36) | SLC6A4SCN4ASLC7A5MAOAPTGS1 | |
| SCHEMBL19586897 | 0.78 | SCN4A (0.42) | SLC6A4SCN4AEPHX1LTA4HCA4 | |
| SCHEMBL16447477 | 0.78 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL9324031 | 0.78 | ACHE (0.48) | LTA4HLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345785-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | BIO RAD LABORATORIES INC (US) | 2025-11-13 | — | — | US | claimed |
| EP-3873955-B1 | AMINO ACID GRAFTED POLYMER WITH SOOT HANDLING PROPERTIES | AFTON CHEMICAL CORP (US) | 2024-12-04 | — | — | EP | claimed |
| US-11896969-B2 | Anionic exchange-hydrophobic mixed mode chromatography resins | BIO-RAD LABORATORIES, INC. (US) | 2024-02-13 | — | — | US | claimed |
| CN-113166334-B | Amino acid grafted polymers with smoke handling properties | 雅富顿化学公司 | 2022-06-21 | — | — | CN | claimed |
| EP-3873955-A1 | AMINO ACID GRAFTED POLYMER WITH SOOT HANDLING PROPERTIES | Afton Chemical Corporation (US) | 2021-09-08 | — | — | EP | claimed |
| CN-113166334-A | Amino acid grafted polymers with smoke handling properties | 雅富顿化学公司 | 2021-07-23 | — | — | CN | claimed |
| US-10899989-B2 | Amino acid grafted polymer with soot handling properties | AFTON CHEMICAL CORPORATION (US) | 2021-01-26 | — | — | US | claimed |
| WO-2020081309-A1 | AMINO ACID GRAFTED POLYMER WITH SOOT HANDLING PROPERTIES | AFTON CHEMICAL CORPORATION (US) | 2020-04-23 | — | — | WO | claimed |
| US-20200115648-A1 | Amino Acid Grafted Polymer with Soot Handling Properties | AFTON CHEMICAL CORPORATION | 2020-04-16 | — | — | US | claimed |
| EP-2276472-B1 | COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS | ADARE PHARMACEUTICALS INC (US) | 2018-11-21 | — | — | EP | claimed |
| EP-0426573-B1 | Phenoxypropylamine derivatives or salts thereof and antiulcer agents containing the same | TERUMO CORP (JP) | 1995-05-24 | — | — | EP | claimed |
| US-5037837-A | 5-lipoxygenase inhibitor | TERUMO KABUSHIKI KAISHA (JP) | 1991-08-06 | — | — | US | claimed |
| EP-0426573-A2 | Phenoxypropylamine derivatives or salts thereof and antiulcer agents containing the same | TERUMO KABUSHIKI KAISHA (JP) | 1991-05-08 | — | — | EP | claimed |
| EP-0358438-A2 | Ethanesulfonamide derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1990-03-14 | — | — | EP | claimed |
| EP-0024510-B1 | PHENOXYPROPYL AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1983-10-19 | — | — | EP | claimed |
| US-4293557-A | AMIDES | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1981-10-06 | — | — | US | claimed |
| EP-0024510-A1 | Phenoxypropyl amine derivatives, process for their preparation, and pharmaceutical compositions containing them | TEIKOKU HORMONE MFG. CO., LTD. (JP) | 1981-03-11 | — | — | EP | claimed |
| US-4034009-A | 4-Ureido-2-acyl phenoxypropanolamine | CHEMIE LINZ AKTIENGESELLSCHAFT (OE) | 1977-07-05 | — | — | US | claimed |
| US-4009275-A | Phenoxypropylamine derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-02-22 | — | — | US | claimed |
| US-3983169-A | Phenoxypropylamine derivatives | CHEMIE LINZ AKTIENGESELLSCHAFT (OE) | 1976-09-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250345785-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | ABCG2, SLC7A1, MSR1 | SLC6A4 234/4885SCN4A 3151/4885SLC7A5 764/4885 |
| US-11896969-B2 | Anionic exchange-hydrophobic mixed mode chromatography resins | ABCG2, SLC7A1, MSR1 | SLC6A4 234/4885SCN4A 3151/4885SLC7A5 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.